000145606 001__ 145606
000145606 005__ 20231212102435.0
000145606 0247_ $$2doi$$a10.1109/CIG.2019.8848110
000145606 037__ $$aDZNE-2020-00936
000145606 041__ $$aEnglish
000145606 1001_ $$0P:(DE-2719)2812503$$aStreck, Adam$$b0$$eFirst author$$udzne
000145606 1112_ $$a2019 IEEE Conference on Games (CoG)$$cLondon$$d2019-08-20 - 2019-08-23$$wUnited Kingdom
000145606 245__ $$aNeomento - Towards building a universal solution for virtual reality exposure psychotherapy
000145606 260__ $$c2019
000145606 3367_ $$033$$2EndNote$$aConference Paper
000145606 3367_ $$2DataCite$$aOther
000145606 3367_ $$2BibTeX$$aINPROCEEDINGS
000145606 3367_ $$2DRIVER$$aconferenceObject
000145606 3367_ $$2ORCID$$aLECTURE_SPEECH
000145606 3367_ $$0PUB:(DE-HGF)6$$2PUB:(DE-HGF)$$aConference Presentation$$bconf$$mconf$$s1702373031_1340$$xOther
000145606 520__ $$aWe present the neomento project, a solution for virtual reality (VR) exposure therapy (VRET). In our work we have created specific rendering methods and virtual environments (VEs), designed and published a novel form of behavioural control for virtual agents (VA), included biophysiological measurements directly into the experience, and created an asymmetric gameplay system to assure the correct progress of a therapy session. The combination of above allows us to overcome multiple of the limitations that were hindering the previously published VRET solutions.
000145606 536__ $$0G:(DE-HGF)POF3-341$$a341 - Molecular Signaling (POF3-341)$$cPOF3-341$$fPOF III$$x0
000145606 536__ $$0G:(DE-HGF)POF3-344$$a344 - Clinical and Health Care Research (POF3-344)$$cPOF3-344$$fPOF III$$x1
000145606 588__ $$aDataset connected to CrossRef Conference
000145606 7001_ $$0P:(DE-2719)2812507$$aStepnicka, Philipp$$b1$$udzne
000145606 7001_ $$0P:(DE-2719)2812504$$aKlaubert, Jens$$b2$$udzne
000145606 7001_ $$0P:(DE-2719)2810583$$aWolbers, Thomas$$b3$$eLast author$$udzne
000145606 773__ $$a10.1109/CIG.2019.8848110
000145606 8564_ $$uhttps://ieeexplore.ieee.org/document/8848110
000145606 8564_ $$uhttps://pub.dzne.de/record/145606/files/DZNE-2020-00936_Restricted.pdf
000145606 8564_ $$uhttps://pub.dzne.de/record/145606/files/DZNE-2020-00936_Restricted.pdf?subformat=pdfa$$xpdfa
000145606 909CO $$ooai:pub.dzne.de:145606$$pVDB
000145606 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)2812503$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b0$$kDZNE
000145606 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)2812507$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b1$$kDZNE
000145606 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)2812504$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b2$$kDZNE
000145606 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)2810583$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b3$$kDZNE
000145606 9131_ $$0G:(DE-HGF)POF3-341$$1G:(DE-HGF)POF3-340$$2G:(DE-HGF)POF3-300$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lErkrankungen des Nervensystems$$vMolecular Signaling$$x0
000145606 9131_ $$0G:(DE-HGF)POF3-344$$1G:(DE-HGF)POF3-340$$2G:(DE-HGF)POF3-300$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lErkrankungen des Nervensystems$$vClinical and Health Care Research$$x1
000145606 9141_ $$y2019
000145606 9201_ $$0I:(DE-2719)1810004$$kAG Schmitz$$lNetwork Dysfunction$$x0
000145606 9201_ $$0I:(DE-2719)1310002$$kAG Wolbers$$lAging, Cognition and Technology$$x1
000145606 980__ $$aconf
000145606 980__ $$aVDB
000145606 980__ $$aI:(DE-2719)1810004
000145606 980__ $$aI:(DE-2719)1310002
000145606 980__ $$aUNRESTRICTED